<DOC>
	<DOCNO>NCT02938507</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics different formulation orally administer solabegron healthy male subject .</brief_summary>
	<brief_title>Evaluate Safety , Tolerability PK Different Formulations Orally Administered Solabegron Healthy Male Subjects</brief_title>
	<detailed_description>The purpose study evaluate safety , tolerability pharmacokinetics different formulation orally administer solabegron healthy male subject . Eligible male subject enrol 2 cohort 12 subject conduct parallel . The study single blind ( subject ) , randomize , cross-over design 3 study period .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solabegron</mesh_term>
	<criteria>Body weight great equal 50 kg , inclusive , body mass index ( BMI ) 18.0 32.0 kg/m2 , inclusive In good general health determine thorough medical history physical examination , ECG , vital sign , clinical laboratory evaluation . Results clinical laboratory test must without clinically significant abnormality , include hematology , clinical chemistry urinalysis . Adequate venous access allow repeat blood sample Ability understand comply study requirement Provide write informed consent prior study procedure perform ( subject able understand inform consent form document subject require read ) . Any clinically relevant abnormality identify screen physical examination , clinical laboratory test , 12lead ECG , medical condition circumstance would make subject unsuitable participation study base Investigator 's assessment Resting heart rate great equal 100 beat per minute ( BPM ) 5 minute rest ( ) screen visit QTcF interval ( Fredericia 's correction factor ) great 450 msec ( male subject ) screen History drug allergy , , opinion Investigator , contraindicate participation History smoking , include ecigarettes , within 3 month study and/or positive urine cotinine screen Regular alcohol consumption average â‰¥ 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month first dose study medication . Positive urine drug alcohol test screen Any condition and/or situation cause Investigator deem subject unsuitable study ( e.g. , due expect study medication noncompliance , inability medically tolerate study procedure , subject 's unwillingness comply studyrelated procedure )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Overactive bladder , Incontinence</keyword>
</DOC>